Mucopolysaccharidosis Type 3B (MPS IIIB, Sanfilippo Syndrome B) Latest Advances

Find the Latest Research About Mucopolysaccharidosis Type 3B (MPS IIIB, Sanfilippo Syndrome B)

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 189 publications

Author Correction: TFEB, FOXO3 and TLR4 in resveratrol-induced autophagy in a mucopolysaccharidosis IIIB mouse model.

Author Correction: TFEB, FOXO3 and TLR4 in resveratrol-induced autophagy in a mucopolysaccharidosis IIIB mouse model.

Journal: Experimental & molecular medicine

Published: March 18, 2026

Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.

Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.

Journal: Biomolecules

Published: December 20, 2025

Comprehensive Characterization of a Cluster of Mucopolysaccharidosis IIIB in Ecuador.

Comprehensive Characterization of a Cluster of Mucopolysaccharidosis IIIB in Ecuador.

Journal: Diagnostics (Basel, Switzerland)

Published: August 06, 2025

Clinical, biochemical, and molecular characterization of a cohort of Egyptian patients with Sanfilippo B syndrome (MPS IIIB): Bayesian Gaussian mixture model.

Clinical, biochemical, and molecular characterization of a cohort of Egyptian patients with Sanfilippo B syndrome (MPS IIIB): Bayesian Gaussian mixture model.

Journal: Molecular biology reports

Published: July 22, 2025

Heparan sulfate binding protein treatment ameliorates neuropathology and behavioral abnormalities in mucopolysaccharidosis IIIB mice.

Heparan sulfate binding protein treatment ameliorates neuropathology and behavioral abnormalities in mucopolysaccharidosis IIIB mice.

Journal: Cell death discovery

Published: May 12, 2025

A Rare Compound Heterozygous NAGLU Gene Mutation in Two Siblings with Mucopolysaccharidosis type Iiib.

A Rare Compound Heterozygous NAGLU Gene Mutation in Two Siblings with Mucopolysaccharidosis type Iiib.

Journal: Iranian journal of pathology

Published: May 05, 2025

Whole-Exome sequencing and systems biology approaches revealed pathogenicity of compound heterozygote variants of NAGLU gene manifesting developmental regression, brain atrophy, intellectual disability, and ADHD.

Whole-Exome sequencing and systems biology approaches revealed pathogenicity of compound heterozygote variants of NAGLU gene manifesting developmental regression, brain atrophy, intellectual disability, and ADHD.

Journal: Molecular biology reports

Published: April 07, 2025

TFEB, FOXO3 and TLR4 in resveratrol-induced autophagy in a mucopolysaccharidosis IIIB mouse model.

TFEB, FOXO3 and TLR4 in resveratrol-induced autophagy in a mucopolysaccharidosis IIIB mouse model.

Journal: Experimental & molecular medicine

Published: February 14, 2025

Shared Gene Expression Dysregulation Across Subtypes of Sanfilippo and Morquio Diseases: The Role of PFN1 in Regulating Glycosaminoglycan Levels.

Shared Gene Expression Dysregulation Across Subtypes of Sanfilippo and Morquio Diseases: The Role of PFN1 in Regulating Glycosaminoglycan Levels.

Journal: Frontiers in bioscience (Landmark edition)

Published: September 30, 2024

A Drosophila model of mucopolysaccharidosis IIIB.

A Drosophila model of mucopolysaccharidosis IIIB.

Journal: Genetics

Published: September 16, 2024

Evidence of epigenetic landscape shifts in mucopolysaccharidosis IIIB and IVA.

Evidence of epigenetic landscape shifts in mucopolysaccharidosis IIIB and IVA.

Journal: Scientific reports

Published: December 13, 2023

Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB.

Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB.

Journal: Journal of neurodevelopmental disorders

Published: September 24, 2023

Showing 1-12 of 189

Last Updated: 04/28/2026